← Back to news
Y

Yahoo Finance

Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates

Y

Baird Lowers Bright Minds Biosciences Inc. (DRUG) Price Target to $126, Maintains Outperform Rating Ahead of Upcoming Trials

Y

Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)’s Science-Driven Psilocybin Therapies as Key Growth Drivers

Y

RBC Capital Cite GH Research PLC’s (GHRS) Long-Term Sales Potential Following Psychedelics Symposium

Y

Edison International Posts Strong 2025 and Sets 2026–2027 EPS Targets

Y

VivoPower $30M PIPE deal fuels AI data centre growth

Y

Target expands stores as customers get fed up with chaos

Y

Joe Rogan Says Warren Buffett, George Soros Are 'Not As Good As' Nancy Pelosi's Husband In Stock Trading, Thinks Politicians 'Know Something'

Y

IRS Grants Tech, Pharma a Tax Break Boost From Trump Deduction

Y

Goldman Sachs See Teva Pharmaceutical Industries Limited (TEVA) Driving Double-Digit Earnings Growth Through 2026

Y

2 Utility Stocks to Buy in February

Y

Rising Energy Demand Will Lift This Stock

Y

Cognex CFO Sees Demand Improving but Wants More Proof of a Durable Upcycle at Conference

Y

What Does the Average Retiree Really Get From Social Security?

Y

Before you buy the software and Big Tech dips, take a closer look at this overseas stock market

Y

Bitcoin Caught Between Hawkish Fed and Dovish Warsh

Y

Occidental Cuts Debt and Lifts Dividend After OxyChem Sale

Y

2 Top Artificial Intelligence Stocks to Buy in February

Y

TrueBlue, Inc. Q4 2025 Earnings Call Summary

Y

Rogers Corporation Q4 2025 Earnings Call Summary

Y

Nextdoor Holdings, Inc. Q4 2025 Earnings Call Summary

Y

Jack in the Box Inc. Q1 2026 Earnings Call Summary

Y

Clearwater Paper Corporation Q4 2025 Earnings Call Summary

Y

Where Will Micron Stock Be in 5 Years?

Y

After Years of Buybacks, Big Oil is Drilling Again

Y

Why Applovin Stock Popped Today

Y

TD Cowen Lowers Aurora Innovation (AUR) PT, Cites Soft 2026 Guidance Despite Growth Inflection Outlook

Y

Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery

Y

Wells Fargo Cites Legend Acquisition Uncertainty as Potential Headwind for Genius Sports (GENI) Valuation

Y

CleanSpark (CLSK): Keefe Bruyette Maintains Positive Outlook on Sealy Project Despite ERCOT Batch Study Uncertainty

Y

PagerDuty (PD): Truist Cites AI Narratives, Terminal Value Concerns as Key Drivers for Infrastructure Software

Y

BofA Lowers Teladoc (TDOC) PT on Peer Multiple Compression, Soft Sensor Tower Trends

Y

Needham Initiates Amprius Technologies (AMPX) as Key Pure-Play Unmanned Aerial Systems Supplier

Y

Is Freshworks (FRSH) One of the Best Single Digit Stocks to Buy According to Analysts?

Y

Citi Lowers Snap (SNAP) PT to $6, Cites Persistent Brand Advertising Headwinds

Y

JPMorgan Initiates TIC Solutions (TIC) Highlighting NV5 Integration and Cross-Selling Synergies

Y

Mahindra Selects Mobileye’s (MBLY) EyeQ6 ADAS for Future Vehicle Lineup

Y

Barclays Adjusts ACV Auctions (ACV) Target Amid Momentum in Used Vehicle Market

Y

Is Brighthouse Financial an Underrated Financial Stock Investment Play?

Y

Utz Brands (UTZ) Q4 2025 Earnings Call Transcript

Y

Wells Fargo Cautious on Praxis Precision (PRAX) After Recent Revenue Estimates

Y

End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations

Y

Morgan Stanley Positive on Cipher Mining (CIFR) Data Center Potential

Y

Analyst Bullish on Beam Therapeutics (BEAM) Over Drug Program Trajectory

Y

Vaxcyte (PCVX) $632.5M Stock Offering Follows Bullish Cantor Fitzgerald Rating

Y

Analysts Bullish on Vera Therapeutics (VERA) Amid New Commercial Chief Appointment

Y

Morgan Stanley Cautious on Nebius (NBIS) Following NVIDIA Platform Deployment

Y

TD Cowen Cautious on Amicus Therapeutics (FOLD) Despite Positive 2025 Revenue Projections

Y

ImmunityBio (IBRX) Clinical Trial for Lymphona Drug Follows $505M Convertible Note Change

Y

Critical Report on Ondas (ONDS) Precedes Defense Unit’s $30M Contract in Israel

Y